Skip to content
Bills from the 2019–20 session

Senate Bill 489

Allowing reimbursement of certain expenses for patients participating in cancer clinical trials

Became law

The governor signed it on Mar 4, 2020. It's ⁠.

  1. Introduced, passed

    Oct 10, 2019

  2. Committee, passed

    Approved

  3. Senate vote, passed

    Passed Jan 21, 2020

  4. Assembly vote, passed

    Passed Feb 20, 2020

  5. Governor, passed

    Signed

  6. Law, here now

    2019 Wisconsin Act 150

Latest entry in the official record, Mar 4, 2020: “Published 3-4-2020”

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it does

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill provides that reimbursement of certain patient-incurred expenses related to participation in a cancer clinical trial will not be considered undue inducement to participate in a cancer clinical trial. Under the bill, reimbursement of travel, ancillary costs, and other direct patient-incurred expenses related to cancer clinical trial participation will not be considered an undue inducement to participate in a cancer clinical trial, and reimbursement for travel and ancillary costs may not be considered coercive or as exerting undue influence to participate in a cancer clinical trial, but rather as a means to create parity in cancer clinical trial access and remove a barrier to participation. The bill requires all sponsors of cancer clinical trials to provide, during the informed consent process, potential participants with information relating to the possible availability of reimbursement for certain expenses. Under the bill, language informing patient-subjects that reimbursement entities or programs that cover travel, ancillary costs, and other direct patient-incurred expenses may be available must be submitted for review to the relevant federally designated institutional review board in conjunction with the review of a proposed cancer clinical trial and included in the informed consent form approved by the institutional review board. The reimbursement entity or program must also disclose the nature of the ancillary support and general guidelines on financial eligibility to interested patient-subjects and employ a reimbursement process that conforms to federal law and guidance.

Who's behind it

9 senators are its ⁠. 5 are Republicans and 4 are Democrats.

23 more lawmakers ⁠.

See all 32 names

Authors (9)

Signed on in support (23)

How lawmakers voted

There was one vote on this bill.

Senate Committee on Health and Human Services vote to recommend it

Passed, 5 to 0 · Jan 8, 2020

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report passage recommended by Committee on Health and Human Services, Ayes 5, Noes 0”. Official record · This vote on its own page

What happened

  1. Mar 4, 2020

    The new law was published.

  2. Mar 4, 2020

    The governor signed it. It became 2019 Wisconsin Act 150.

  3. Feb 28, 2020

    Sent to the governor.

  4. Feb 20, 2020

    The Assembly passed it too.

  5. Feb 18, 2020

    Sent to the Assembly Committee on Rules.

  6. Jan 21, 2020

    The Assembly received it.

  7. Jan 21, 2020

    1 more senator signed on in support.

  8. Jan 21, 2020

    The Senate passed it.

  9. Jan 8, 2020

    The committee voted to recommend passing it, 5 to 0.

  10. Nov 20, 2019

    1 more representative signed on in support.

  11. Nov 20, 2019

    The committee held a public hearing.

  12. Oct 14, 2019 to Oct 18, 2019

    2 more representatives signed on in support.

  13. Oct 10, 2019

    Sent to the Senate Committee on Health and Human Services.

  14. Oct 10, 2019

    Introduced in the Senate.

See the official record, word for word
  1. Oct 10, 2019 · Senate

    Introduced by Senators Kooyenga, Darling, Carpenter, Erpenbach, Jacque, L. Taylor, Smith, Olsen and Craig; cosponsored by Representatives Kulp, Duchow, Rodriguez, Dittrich, Sinicki, Skowronski, Tittl, Steffen, Spiros, Ott, Mursau, Knodl, Kerkman, Horlacher, Felzkowski, Ballweg, Anderson, Allen and C. Taylor

  2. Oct 10, 2019 · Senate

    Read first time and referred to Committee on Health and Human Services

  3. Oct 14, 2019 · Senate

    Representative Tusler added as a cosponsor

  4. Oct 18, 2019 · Senate

    Representative Subeck added as a cosponsor

  5. Nov 20, 2019 · Senate

    Public hearing held

  6. Nov 20, 2019 · Senate

    Representative Snyder added as a cosponsor

  7. Jan 8, 2020 · Senate

    Executive action taken

  8. Jan 8, 2020 · Senate

    Report passage recommended by Committee on Health and Human Services, Ayes 5, Noes 0

  9. Jan 8, 2020 · Senate

    Available for scheduling

  10. Jan 17, 2020 · Senate

    Placed on calendar 1-21-2020 pursuant to Senate Rule 18(1)

  11. Jan 21, 2020 · Senate

    Read a second time

  12. Jan 21, 2020 · Senate

    Ordered to a third reading

  13. Jan 21, 2020 · Senate

    Rules suspended

  14. Jan 21, 2020 · Senate

    Read a third time and passed

  15. Jan 21, 2020 · Senate

    Senator Bewley added as a coauthor

  16. Jan 21, 2020 · Senate

    Ordered immediately messaged

  17. Jan 21, 2020 · Assembly

    Received from Senate

  18. Feb 18, 2020 · Assembly

    Read first time and referred to committee on Rules

  19. Feb 18, 2020 · Assembly

    Made a special order of business at 11:44 AM on 2-20-2020 pursuant to Assembly Resolution 21

  20. Feb 20, 2020 · Assembly

    Read a second time

  21. Feb 20, 2020 · Assembly

    Ordered to a third reading

  22. Feb 20, 2020 · Assembly

    Rules suspended

  23. Feb 20, 2020 · Assembly

    Read a third time and concurred in

  24. Feb 20, 2020 · Assembly

    Ordered immediately messaged

  25. Feb 21, 2020 · Senate

    Received from Assembly concurred in

  26. Feb 25, 2020 · Senate

    Report correctly enrolled

  27. Feb 28, 2020 · Senate

    Presented to the Governor on 2-28-2020

  28. Mar 4, 2020 · Senate

    Report approved by the Governor on 3-3-2020. 2019 Wisconsin Act 150

  29. Mar 4, 2020 · Senate

    Published 3-4-2020

Terms on this page

Wisconsin Act

The number a bill gets when it becomes law, like 2025 Wisconsin Act 12.

Official term: Act. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Wisconsin Act

The number a bill gets when it becomes law, like 2025 Wisconsin Act 12.

Official term: Act

More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote

More in the glossary